ORIC — ORIC Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $892.18m
- $610.70m
Annual cashflow statement for ORIC Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -78.7 | -89.1 | -101 | -128 | -129 |
| Depreciation | |||||
| Non-Cash Items | 14.2 | 13.5 | 9.08 | 12.1 | 22.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.07 | -0.445 | 4.9 | 1.97 | -5.46 |
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -59.5 | -75.1 | -85.7 | -113 | -111 |
| Capital Expenditures | -0.939 | -2.08 | -0.849 | -1.19 | -0.712 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 159 | -107 | -42.6 | 23.3 | -147 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 158 | -109 | -43.4 | 22.1 | -148 |
| Financing Cash Flow Items | -1.85 | -0.399 | -0.227 | -0.168 | -2.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 49.1 | 25.2 | 85.7 | 127 | 245 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 148 | -159 | -43.4 | 36 | -13.7 |